

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 9.91694531 |
| 2 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 9.91694531 |
| 3 | neutrophil mediated immunity (GO:0002446) | 8.99531046 |
| 4 | negative regulation of growth of symbiont in host (GO:0044130) | 7.62770366 |
| 5 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 7.62770366 |
| 6 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 7.62770366 |
| 7 | regulation of growth of symbiont in host (GO:0044126) | 7.62770366 |
| 8 | killing of cells of other organism (GO:0031640) | 7.51111828 |
| 9 | disruption of cells of other organism (GO:0044364) | 7.51111828 |
| 10 | negative regulation of phagocytosis (GO:0050765) | 7.34560480 |
| 11 | defense response to fungus (GO:0050832) | 7.31671646 |
| 12 | myeloid leukocyte mediated immunity (GO:0002444) | 7.28580570 |
| 13 | response to fungus (GO:0009620) | 6.93120123 |
| 14 | innate immune response in mucosa (GO:0002227) | 6.79579832 |
| 15 | cellular extravasation (GO:0045123) | 6.70336963 |
| 16 | cell wall macromolecule catabolic process (GO:0016998) | 6.52724655 |
| 17 | antibacterial humoral response (GO:0019731) | 5.93612486 |
| 18 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.62448278 |
| 19 | antimicrobial humoral response (GO:0019730) | 5.44572102 |
| 20 | mucosal immune response (GO:0002385) | 5.43654229 |
| 21 | cell wall macromolecule metabolic process (GO:0044036) | 5.39438161 |
| 22 | leukocyte mediated cytotoxicity (GO:0001909) | 5.20025515 |
| 23 | organ or tissue specific immune response (GO:0002251) | 5.18635183 |
| 24 | cellular response to zinc ion (GO:0071294) | 5.02828359 |
| 25 | DNA deamination (GO:0045006) | 4.95799495 |
| 26 | respiratory burst (GO:0045730) | 4.95771859 |
| 27 | reactive oxygen species biosynthetic process (GO:1903409) | 4.90425586 |
| 28 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.82704007 |
| 29 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.80679010 |
| 30 | ribosomal small subunit assembly (GO:0000028) | 4.41309492 |
| 31 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.39916382 |
| 32 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.37237772 |
| 33 | imidazole-containing compound metabolic process (GO:0052803) | 4.37121901 |
| 34 | pentose-phosphate shunt (GO:0006098) | 4.27497565 |
| 35 | positive regulation of B cell differentiation (GO:0045579) | 4.24838070 |
| 36 | DNA strand elongation (GO:0022616) | 4.21065414 |
| 37 | NADPH regeneration (GO:0006740) | 4.02569679 |
| 38 | cell killing (GO:0001906) | 3.87882761 |
| 39 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.86977310 |
| 40 | protein localization to kinetochore (GO:0034501) | 3.79356771 |
| 41 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.76173361 |
| 42 | hemoglobin metabolic process (GO:0020027) | 3.76127650 |
| 43 | microglial cell activation (GO:0001774) | 3.73684387 |
| 44 | glucose 6-phosphate metabolic process (GO:0051156) | 3.71088936 |
| 45 | negative regulation of bone mineralization (GO:0030502) | 3.69569627 |
| 46 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.69424768 |
| 47 | positive regulation of mast cell degranulation (GO:0043306) | 3.69424768 |
| 48 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.68438321 |
| 49 | leukotriene biosynthetic process (GO:0019370) | 3.66542058 |
| 50 | telomere maintenance via recombination (GO:0000722) | 3.66399957 |
| 51 | positive regulation of granulocyte differentiation (GO:0030854) | 3.65313005 |
| 52 | DNA replication initiation (GO:0006270) | 3.64848362 |
| 53 | regulation of mast cell degranulation (GO:0043304) | 3.62384300 |
| 54 | sequestering of metal ion (GO:0051238) | 3.62245673 |
| 55 | pentose metabolic process (GO:0019321) | 3.60394126 |
| 56 | angiotensin maturation (GO:0002003) | 3.60075739 |
| 57 | neutrophil activation involved in immune response (GO:0002283) | 3.59562261 |
| 58 | defense response to Gram-positive bacterium (GO:0050830) | 3.56765980 |
| 59 | oxygen transport (GO:0015671) | 3.52258767 |
| 60 | DNA unwinding involved in DNA replication (GO:0006268) | 3.51593375 |
| 61 | regulation of chemokine biosynthetic process (GO:0045073) | 3.51192501 |
| 62 | granulocyte activation (GO:0036230) | 3.49469814 |
| 63 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.47302337 |
| 64 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.47135072 |
| 65 | negative regulation of chemokine production (GO:0032682) | 3.46468458 |
| 66 | interaction with symbiont (GO:0051702) | 3.45084297 |
| 67 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.43278942 |
| 68 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.42043858 |
| 69 | IMP metabolic process (GO:0046040) | 3.40591603 |
| 70 | mitotic recombination (GO:0006312) | 3.37118718 |
| 71 | definitive hemopoiesis (GO:0060216) | 3.35895243 |
| 72 | detection of other organism (GO:0098543) | 3.33719312 |
| 73 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.33291661 |
| 74 | DNA replication checkpoint (GO:0000076) | 3.32043313 |
| 75 | positive regulation of mast cell activation (GO:0033005) | 3.31687465 |
| 76 | leukocyte degranulation (GO:0043299) | 3.29835053 |
| 77 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.29745641 |
| 78 | response to muramyl dipeptide (GO:0032495) | 3.27645103 |
| 79 | protein localization to chromosome, centromeric region (GO:0071459) | 3.25073997 |
| 80 | secretory granule organization (GO:0033363) | 3.23658993 |
| 81 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.23266643 |
| 82 | hydrogen peroxide catabolic process (GO:0042744) | 3.20956141 |
| 83 | detection of bacterium (GO:0016045) | 3.20428266 |
| 84 | response to peptidoglycan (GO:0032494) | 3.20265185 |
| 85 | defense response to bacterium (GO:0042742) | 3.19876504 |
| 86 | regulation of female gonad development (GO:2000194) | 3.19777913 |
| 87 | leukotriene metabolic process (GO:0006691) | 3.18063991 |
| 88 | cotranslational protein targeting to membrane (GO:0006613) | 3.17007147 |
| 89 | negative regulation of biomineral tissue development (GO:0070168) | 3.14845668 |
| 90 | leukocyte aggregation (GO:0070486) | 3.14516703 |
| 91 | protein targeting to ER (GO:0045047) | 3.13807875 |
| 92 | peptide catabolic process (GO:0043171) | 3.12499028 |
| 93 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.10395476 |
| 94 | telomere maintenance via telomere lengthening (GO:0010833) | 3.10353448 |
| 95 | signal peptide processing (GO:0006465) | 3.09929090 |
| 96 | regulation of leukocyte degranulation (GO:0043300) | 3.09646658 |
| 97 | low-density lipoprotein particle remodeling (GO:0034374) | 3.09470899 |
| 98 | modification by host of symbiont morphology or physiology (GO:0051851) | 3.04664005 |
| 99 | natural killer cell activation involved in immune response (GO:0002323) | 3.04490370 |
| 100 | negative regulation of interleukin-8 production (GO:0032717) | 3.03600574 |
| 101 | regulation of mast cell activation (GO:0033003) | 3.03558991 |
| 102 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.03448350 |
| 103 | IMP biosynthetic process (GO:0006188) | 3.01009317 |
| 104 | protein localization to endoplasmic reticulum (GO:0070972) | 3.00540098 |
| 105 | angiogenesis involved in wound healing (GO:0060055) | 2.99694355 |
| 106 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.97696563 |
| 107 | gas transport (GO:0015669) | 2.96030723 |
| 108 | nucleobase biosynthetic process (GO:0046112) | 2.94545370 |
| 109 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.93606839 |
| 110 | macrophage differentiation (GO:0030225) | 2.93475320 |
| 111 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.90233738 |
| 112 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.90233738 |
| 113 | glucose catabolic process (GO:0006007) | 2.88247618 |
| 114 | CENP-A containing nucleosome assembly (GO:0034080) | 2.87127942 |
| 115 | regulation of B cell differentiation (GO:0045577) | 2.85433713 |
| 116 | centriole replication (GO:0007099) | 2.83863200 |
| 117 | myeloid cell activation involved in immune response (GO:0002275) | 2.83492947 |
| 118 | regulation of regulated secretory pathway (GO:1903305) | 2.83430495 |
| 119 | regulation of hypersensitivity (GO:0002883) | 2.82640098 |
| 120 | kinetochore organization (GO:0051383) | 2.81946096 |
| 121 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.80671529 |
| 122 | response to bacterium (GO:0009617) | 2.79120461 |
| 123 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.78802972 |
| 124 | mast cell activation (GO:0045576) | 2.78170732 |
| 125 | viral transcription (GO:0019083) | 2.74476275 |
| 126 | chromatin remodeling at centromere (GO:0031055) | 2.73930546 |
| 127 | positive regulation of regulated secretory pathway (GO:1903307) | 2.73928648 |
| 128 | translational termination (GO:0006415) | 2.68808461 |
| 129 | DNA topological change (GO:0006265) | 2.68627014 |
| 130 | intra-S DNA damage checkpoint (GO:0031573) | 2.65968107 |
| 131 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.65440781 |
| 132 | macrophage activation (GO:0042116) | 2.64503903 |
| 133 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.58884306 |
| 134 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.57315968 |
| 135 | pinocytosis (GO:0006907) | 2.57183564 |
| 136 | B cell receptor signaling pathway (GO:0050853) | 2.56527102 |
| 137 | erythrocyte development (GO:0048821) | 2.54667182 |
| 138 | translational elongation (GO:0006414) | 2.53456943 |
| 139 | regulation of phagocytosis (GO:0050764) | 2.53435307 |
| 140 | ether lipid metabolic process (GO:0046485) | 2.53406034 |
| 141 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.53335645 |
| 142 | mitotic nuclear envelope disassembly (GO:0007077) | 2.51926422 |
| 143 | tetrapyrrole biosynthetic process (GO:0033014) | 2.51813197 |
| 144 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.51703990 |
| 145 | negative regulation of interleukin-6 production (GO:0032715) | 2.51396461 |
| 146 | cellular response to exogenous dsRNA (GO:0071360) | 2.51079079 |
| 147 | pseudouridine synthesis (GO:0001522) | 2.49907343 |
| 148 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.44473732 |
| 149 | ribosome assembly (GO:0042255) | 2.44359855 |
| 150 | neutrophil activation (GO:0042119) | 2.43372064 |
| 151 | actin nucleation (GO:0045010) | 2.42431858 |
| 152 | purine nucleobase metabolic process (GO:0006144) | 2.41233324 |
| 153 | inflammatory response to antigenic stimulus (GO:0002437) | 2.40870898 |
| 154 | mitochondrial calcium ion transport (GO:0006851) | 2.40373489 |
| 155 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.40282165 |
| 156 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.38257076 |
| 157 | necroptotic process (GO:0070266) | 2.38137136 |
| 158 | heme biosynthetic process (GO:0006783) | 2.37936111 |
| 159 | negative regulation of granulocyte differentiation (GO:0030853) | 2.36797283 |
| 160 | Golgi transport vesicle coating (GO:0048200) | 2.35800355 |
| 161 | COPI coating of Golgi vesicle (GO:0048205) | 2.35800355 |
| 162 | hydrogen peroxide metabolic process (GO:0042743) | 2.35400584 |
| 163 | anterograde synaptic vesicle transport (GO:0048490) | 2.35361208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.22500076 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.81395279 |
| 3 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.48498398 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.37675520 |
| 5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.35505629 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.09486595 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.04225043 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.02848456 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.90569904 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.85575810 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.79230817 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.70357406 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.57938285 |
| 14 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.53177059 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.43259768 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.39302231 |
| 17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.37557198 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.37222556 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.27813475 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.24474952 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.16278762 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.14921547 |
| 23 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.14836552 |
| 24 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.09194283 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05864332 |
| 26 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05156577 |
| 27 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.99011037 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94462259 |
| 29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.93623580 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.93445818 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.91542168 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89507320 |
| 33 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.89162280 |
| 34 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.86866263 |
| 35 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85839275 |
| 36 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.84917816 |
| 37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.84079800 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.81724639 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.81585855 |
| 40 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.80264395 |
| 41 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.79196288 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.78085993 |
| 43 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.76790384 |
| 44 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.74017589 |
| 45 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.73631419 |
| 46 | GATA1_19941826_ChIP-Seq_K562_Human | 1.73387945 |
| 47 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.72374507 |
| 48 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.58626241 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.58389963 |
| 50 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57608951 |
| 51 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.57452605 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.56972270 |
| 53 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.56026531 |
| 54 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.55257355 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54824698 |
| 56 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.54555887 |
| 57 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53520370 |
| 58 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.52456461 |
| 59 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.44939151 |
| 60 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.44014816 |
| 61 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43435907 |
| 62 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43205290 |
| 63 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.42107017 |
| 64 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.41856328 |
| 65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40086340 |
| 66 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.39553936 |
| 67 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39276635 |
| 68 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.38464748 |
| 69 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.38218170 |
| 70 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.37260212 |
| 71 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.36885742 |
| 72 | MYB_26560356_Chip-Seq_TH2_Human | 1.36492029 |
| 73 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.35756313 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34798831 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34326322 |
| 76 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31447818 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30954292 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30339365 |
| 79 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.29940625 |
| 80 | GATA2_19941826_ChIP-Seq_K562_Human | 1.28721507 |
| 81 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.27612970 |
| 82 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27561966 |
| 83 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.26923694 |
| 84 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26581922 |
| 85 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.25006875 |
| 86 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.24401465 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 1.24295014 |
| 88 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.23927584 |
| 89 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23748443 |
| 90 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.23462083 |
| 91 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22709335 |
| 92 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.21955646 |
| 93 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.18984897 |
| 94 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18618239 |
| 95 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.18029771 |
| 96 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17329087 |
| 97 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17212705 |
| 98 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16645920 |
| 99 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16102745 |
| 100 | MYB_26560356_Chip-Seq_TH1_Human | 1.15772281 |
| 101 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14458432 |
| 102 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14353536 |
| 103 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.13773836 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13591842 |
| 105 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.13476107 |
| 106 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13460830 |
| 107 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12419712 |
| 108 | MAF_26560356_Chip-Seq_TH1_Human | 1.11450499 |
| 109 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10429189 |
| 110 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07807183 |
| 111 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06312936 |
| 112 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.03878183 |
| 113 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.03202606 |
| 114 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.01775810 |
| 115 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01511553 |
| 116 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01246027 |
| 117 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.00391990 |
| 118 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99495456 |
| 119 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97955780 |
| 120 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.97730463 |
| 121 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.97354884 |
| 122 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94828046 |
| 123 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94619984 |
| 124 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94466514 |
| 125 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.93429020 |
| 126 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.93202515 |
| 127 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92454178 |
| 128 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91489055 |
| 129 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91436301 |
| 130 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.90230278 |
| 131 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88867378 |
| 132 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.88457620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.07374112 |
| 2 | MP0002396_abnormal_hematopoietic_system | 4.05066534 |
| 3 | MP0003303_peritoneal_inflammation | 3.38644423 |
| 4 | MP0003436_decreased_susceptibility_to | 3.21568536 |
| 5 | MP0003183_abnormal_peptide_metabolism | 3.06271467 |
| 6 | MP0010094_abnormal_chromosome_stability | 2.97026892 |
| 7 | MP0008057_abnormal_DNA_replication | 2.92263988 |
| 8 | MP0009785_altered_susceptibility_to | 2.90737762 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.90308778 |
| 10 | MP0002419_abnormal_innate_immunity | 2.88825406 |
| 11 | MP0009278_abnormal_bone_marrow | 2.79165524 |
| 12 | MP0003111_abnormal_nucleus_morphology | 2.68920522 |
| 13 | MP0003724_increased_susceptibility_to | 2.62107775 |
| 14 | MP0005174_abnormal_tail_pigmentation | 2.52501451 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.42033927 |
| 16 | MP0000490_abnormal_crypts_of | 2.40201153 |
| 17 | MP0005083_abnormal_biliary_tract | 2.40144735 |
| 18 | MP0000569_abnormal_digit_pigmentation | 2.39835979 |
| 19 | MP0005025_abnormal_response_to | 2.39345787 |
| 20 | MP0001835_abnormal_antigen_presentation | 2.38082258 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.38053603 |
| 22 | MP0004957_abnormal_blastocyst_morpholog | 2.36780678 |
| 23 | MP0003077_abnormal_cell_cycle | 2.28805131 |
| 24 | MP0000465_gastrointestinal_hemorrhage | 2.23291120 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.16852280 |
| 26 | MP0008058_abnormal_DNA_repair | 1.98809764 |
| 27 | MP0002420_abnormal_adaptive_immunity | 1.93513488 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.91523027 |
| 29 | MP0005075_abnormal_melanosome_morpholog | 1.91063593 |
| 30 | MP0006082_CNS_inflammation | 1.89687690 |
| 31 | MP0001819_abnormal_immune_cell | 1.88919495 |
| 32 | MP0002006_tumorigenesis | 1.85917071 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.85419365 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.85419365 |
| 35 | MP0000858_altered_metastatic_potential | 1.81488488 |
| 36 | MP0000015_abnormal_ear_pigmentation | 1.78738031 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.77802332 |
| 38 | MP0006054_spinal_hemorrhage | 1.75269182 |
| 39 | MP0001853_heart_inflammation | 1.74756526 |
| 40 | MP0002398_abnormal_bone_marrow | 1.72140293 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.67558319 |
| 42 | MP0000716_abnormal_immune_system | 1.63461022 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.60270473 |
| 44 | MP0002452_abnormal_antigen_presenting | 1.55019718 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.53649558 |
| 46 | MP0002722_abnormal_immune_system | 1.53220569 |
| 47 | MP0002429_abnormal_blood_cell | 1.53065810 |
| 48 | MP0003186_abnormal_redox_activity | 1.51899570 |
| 49 | MP0002723_abnormal_immune_serum | 1.51060796 |
| 50 | MP0010307_abnormal_tumor_latency | 1.48435026 |
| 51 | MP0002095_abnormal_skin_pigmentation | 1.47932435 |
| 52 | MP0005671_abnormal_response_to | 1.47448092 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.45789682 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.44073772 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.43215459 |
| 56 | MP0008995_early_reproductive_senescence | 1.40204286 |
| 57 | MP0002405_respiratory_system_inflammati | 1.39552444 |
| 58 | MP0002019_abnormal_tumor_incidence | 1.38528837 |
| 59 | MP0001800_abnormal_humoral_immune | 1.38523746 |
| 60 | MP0008007_abnormal_cellular_replicative | 1.38310480 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.37386337 |
| 62 | MP0009764_decreased_sensitivity_to | 1.35690971 |
| 63 | MP0003828_pulmonary_edema | 1.32309863 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.32065756 |
| 65 | MP0009379_abnormal_foot_pigmentation | 1.30759364 |
| 66 | MP0000343_altered_response_to | 1.28163369 |
| 67 | MP0005360_urolithiasis | 1.27172279 |
| 68 | MP0003656_abnormal_erythrocyte_physiolo | 1.26431835 |
| 69 | MP0001663_abnormal_digestive_system | 1.26225884 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 1.26061530 |
| 71 | MP0004185_abnormal_adipocyte_glucose | 1.24757968 |
| 72 | MP0003806_abnormal_nucleotide_metabolis | 1.23074978 |
| 73 | MP0008961_abnormal_basal_metabolism | 1.21953518 |
| 74 | MP0003866_abnormal_defecation | 1.20487205 |
| 75 | MP0005058_abnormal_lysosome_morphology | 1.19365117 |
| 76 | MP0000685_abnormal_immune_system | 1.17410138 |
| 77 | MP0003221_abnormal_cardiomyocyte_apopto | 1.15379500 |
| 78 | MP0002132_abnormal_respiratory_system | 1.14448729 |
| 79 | MP0004782_abnormal_surfactant_physiolog | 1.14309582 |
| 80 | MP0002877_abnormal_melanocyte_morpholog | 1.09037068 |
| 81 | MP0006036_abnormal_mitochondrial_physio | 1.08767580 |
| 82 | MP0008260_abnormal_autophagy | 1.08397310 |
| 83 | MP0001764_abnormal_homeostasis | 1.06867140 |
| 84 | MP0000703_abnormal_thymus_morphology | 1.06325283 |
| 85 | MP0005409_darkened_coat_color | 1.05095554 |
| 86 | MP0001873_stomach_inflammation | 1.04819548 |
| 87 | MP0003786_premature_aging | 1.03501280 |
| 88 | MP0008469_abnormal_protein_level | 1.02563784 |
| 89 | MP0004264_abnormal_extraembryonic_tissu | 1.01619152 |
| 90 | MP0004947_skin_inflammation | 1.01433204 |
| 91 | MP0001851_eye_inflammation | 1.00748109 |
| 92 | MP0000350_abnormal_cell_proliferation | 1.00031636 |
| 93 | MP0000313_abnormal_cell_death | 0.98839495 |
| 94 | MP0008932_abnormal_embryonic_tissue | 0.98573830 |
| 95 | MP0008873_increased_physiological_sensi | 0.95952406 |
| 96 | MP0005164_abnormal_response_to | 0.91429725 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 0.91308048 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.89804627 |
| 99 | MP0000598_abnormal_liver_morphology | 0.89615885 |
| 100 | MP0000358_abnormal_cell_content/ | 0.88539183 |
| 101 | MP0003075_altered_response_to | 0.88464172 |
| 102 | MP0003638_abnormal_response/metabolism_ | 0.81812527 |
| 103 | MP0000249_abnormal_blood_vessel | 0.79712880 |
| 104 | MP0002735_abnormal_chemical_nociception | 0.79387242 |
| 105 | MP0001790_abnormal_immune_system | 0.79324821 |
| 106 | MP0005387_immune_system_phenotype | 0.79324821 |
| 107 | MP0009115_abnormal_fat_cell | 0.76827345 |
| 108 | MP0000681_abnormal_thyroid_gland | 0.75513623 |
| 109 | MP0002971_abnormal_brown_adipose | 0.73508127 |
| 110 | MP0009763_increased_sensitivity_to | 0.72354362 |
| 111 | MP0004883_abnormal_blood_vessel | 0.70632704 |
| 112 | MP0001730_embryonic_growth_arrest | 0.69850025 |
| 113 | MP0005220_abnormal_exocrine_pancreas | 0.69220914 |
| 114 | MP0003300_gastrointestinal_ulcer | 0.68902649 |
| 115 | MP0002998_abnormal_bone_remodeling | 0.68558765 |
| 116 | MP0005266_abnormal_metabolism | 0.68430420 |
| 117 | MP0003123_paternal_imprinting | 0.68322815 |
| 118 | MP0005408_hypopigmentation | 0.66985308 |
| 119 | MP0004134_abnormal_chest_morphology | 0.66951323 |
| 120 | MP0005381_digestive/alimentary_phenotyp | 0.66473141 |
| 121 | MP0005376_homeostasis/metabolism_phenot | 0.65049865 |
| 122 | MP0005384_cellular_phenotype | 0.63538173 |
| 123 | MP0000371_diluted_coat_color | 0.61910894 |
| 124 | MP0002009_preneoplasia | 0.61549754 |
| 125 | MP0004147_increased_porphyrin_level | 0.60775076 |
| 126 | MP0002089_abnormal_postnatal_growth/wei | 0.58462682 |
| 127 | MP0002970_abnormal_white_adipose | 0.58143429 |
| 128 | MP0005621_abnormal_cell_physiology | 0.56546835 |
| 129 | MP0002080_prenatal_lethality | 0.56401968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thrombocytosis (HP:0001894) | 7.63290929 |
| 2 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.92502611 |
| 3 | Obstructive lung disease (HP:0006536) | 5.35643737 |
| 4 | Chronic obstructive pulmonary disease (HP:0006510) | 5.35643737 |
| 5 | Abnormality of the prostate (HP:0008775) | 4.94726648 |
| 6 | Hypochromic microcytic anemia (HP:0004840) | 4.90274370 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.74761118 |
| 8 | Reduced antithrombin III activity (HP:0001976) | 4.67114207 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.52632902 |
| 10 | Amyloidosis (HP:0011034) | 4.50496929 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.42642443 |
| 12 | Periodontitis (HP:0000704) | 4.21619611 |
| 13 | Type I transferrin isoform profile (HP:0003642) | 4.16373273 |
| 14 | Chest pain (HP:0100749) | 3.97083517 |
| 15 | Abnormal number of erythroid precursors (HP:0012131) | 3.82851583 |
| 16 | Eosinophilia (HP:0001880) | 3.81321370 |
| 17 | Reticulocytopenia (HP:0001896) | 3.80727332 |
| 18 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.64861297 |
| 19 | Granulocytopenia (HP:0001913) | 3.63959432 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.61452725 |
| 21 | Acute lymphatic leukemia (HP:0006721) | 3.48569781 |
| 22 | Prolonged bleeding time (HP:0003010) | 3.45471061 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.44126435 |
| 24 | Myositis (HP:0100614) | 3.40005009 |
| 25 | Aplastic anemia (HP:0001915) | 3.39658171 |
| 26 | Ureteral stenosis (HP:0000071) | 3.38885511 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.34294795 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.34294795 |
| 29 | Meningitis (HP:0001287) | 3.34132267 |
| 30 | Abnormal protein glycosylation (HP:0012346) | 3.31551690 |
| 31 | Abnormal glycosylation (HP:0012345) | 3.31551690 |
| 32 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.31551690 |
| 33 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.31551690 |
| 34 | Papilledema (HP:0001085) | 3.28607692 |
| 35 | Pulmonary fibrosis (HP:0002206) | 3.22843118 |
| 36 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.21356674 |
| 37 | Abnormality of B cell number (HP:0010975) | 3.07611532 |
| 38 | B lymphocytopenia (HP:0010976) | 3.07611532 |
| 39 | Hypochromic anemia (HP:0001931) | 3.06797019 |
| 40 | Petechiae (HP:0000967) | 3.05693007 |
| 41 | Microcytic anemia (HP:0001935) | 3.03654301 |
| 42 | Gangrene (HP:0100758) | 3.00345408 |
| 43 | IgM deficiency (HP:0002850) | 2.96649623 |
| 44 | Ureteral obstruction (HP:0006000) | 2.96441167 |
| 45 | Poikilocytosis (HP:0004447) | 2.95262536 |
| 46 | Hepatosplenomegaly (HP:0001433) | 2.92548605 |
| 47 | Poikiloderma (HP:0001029) | 2.92528516 |
| 48 | Abnormal hemoglobin (HP:0011902) | 2.91311053 |
| 49 | Autoimmune thrombocytopenia (HP:0001973) | 2.88659195 |
| 50 | Hemoptysis (HP:0002105) | 2.85354470 |
| 51 | Polycythemia (HP:0001901) | 2.79050398 |
| 52 | Mediastinal lymphadenopathy (HP:0100721) | 2.76931398 |
| 53 | Pulmonary infiltrates (HP:0002113) | 2.76839653 |
| 54 | Abnormality of iron homeostasis (HP:0011031) | 2.74122969 |
| 55 | Chromsome breakage (HP:0040012) | 2.73085981 |
| 56 | Abnormality of the pleura (HP:0002103) | 2.69743388 |
| 57 | Abnormality of eosinophils (HP:0001879) | 2.69552349 |
| 58 | Neutropenia (HP:0001875) | 2.68671190 |
| 59 | Hypergammaglobulinemia (HP:0010702) | 2.64972336 |
| 60 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.63183036 |
| 61 | Abnormality of T cell physiology (HP:0011840) | 2.61722996 |
| 62 | Recurrent skin infections (HP:0001581) | 2.60506592 |
| 63 | Epistaxis (HP:0000421) | 2.54719095 |
| 64 | Increased serum ferritin (HP:0003281) | 2.53354192 |
| 65 | Leukocytosis (HP:0001974) | 2.51971845 |
| 66 | Panhypogammaglobulinemia (HP:0003139) | 2.50835058 |
| 67 | Gingival bleeding (HP:0000225) | 2.48722397 |
| 68 | Abnormality of the thoracic spine (HP:0100711) | 2.47996046 |
| 69 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.47776082 |
| 70 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.47611266 |
| 71 | Paralysis (HP:0003470) | 2.45760659 |
| 72 | Abnormality of macrophages (HP:0004311) | 2.44790032 |
| 73 | Abnormality of DNA repair (HP:0003254) | 2.40297446 |
| 74 | Chronic otitis media (HP:0000389) | 2.39842659 |
| 75 | Abnormality of male internal genitalia (HP:0000022) | 2.39662194 |
| 76 | Entropion (HP:0000621) | 2.37916358 |
| 77 | Vasculitis (HP:0002633) | 2.37621754 |
| 78 | Pallor (HP:0000980) | 2.35859014 |
| 79 | Thoracic kyphosis (HP:0002942) | 2.35564156 |
| 80 | Increased cerebral lipofuscin (HP:0011813) | 2.33434580 |
| 81 | Duplicated collecting system (HP:0000081) | 2.30038935 |
| 82 | J-shaped sella turcica (HP:0002680) | 2.29756304 |
| 83 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.29435066 |
| 84 | Skin ulcer (HP:0200042) | 2.27944664 |
| 85 | Agammaglobulinemia (HP:0004432) | 2.26285176 |
| 86 | Oral leukoplakia (HP:0002745) | 2.24161726 |
| 87 | Sepsis (HP:0100806) | 2.22183735 |
| 88 | Paresthesia (HP:0003401) | 2.21432197 |
| 89 | Bone marrow hypocellularity (HP:0005528) | 2.19963166 |
| 90 | Cellulitis (HP:0100658) | 2.19316479 |
| 91 | Gingivitis (HP:0000230) | 2.17732476 |
| 92 | Thrombophlebitis (HP:0004418) | 2.15767038 |
| 93 | Glomerulopathy (HP:0100820) | 2.15184679 |
| 94 | Recurrent fungal infections (HP:0002841) | 2.15080548 |
| 95 | Fatigue (HP:0012378) | 2.14187912 |
| 96 | Reticulocytosis (HP:0001923) | 2.13878229 |
| 97 | Myelodysplasia (HP:0002863) | 2.13862974 |
| 98 | Autoimmune hemolytic anemia (HP:0001890) | 2.12681852 |
| 99 | Restrictive lung disease (HP:0002091) | 2.12168975 |
| 100 | Cutaneous melanoma (HP:0012056) | 2.10930937 |
| 101 | Spondylolisthesis (HP:0003302) | 2.10043841 |
| 102 | Agnosia (HP:0010524) | 2.08406196 |
| 103 | Amaurosis fugax (HP:0100576) | 2.06458978 |
| 104 | Pancytopenia (HP:0001876) | 2.05731177 |
| 105 | Degeneration of anterior horn cells (HP:0002398) | 2.05513208 |
| 106 | Abnormality of the anterior horn cell (HP:0006802) | 2.05513208 |
| 107 | Encephalitis (HP:0002383) | 2.05274499 |
| 108 | Neurodegeneration (HP:0002180) | 2.05099551 |
| 109 | Vacuolated lymphocytes (HP:0001922) | 2.04223955 |
| 110 | Dysostosis multiplex (HP:0000943) | 2.02988222 |
| 111 | Severe visual impairment (HP:0001141) | 2.01777746 |
| 112 | Abnormality of T cells (HP:0002843) | 2.00727151 |
| 113 | Pulmonary embolism (HP:0002204) | 2.00106277 |
| 114 | Cholelithiasis (HP:0001081) | 1.99923512 |
| 115 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.99172206 |
| 116 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.99172206 |
| 117 | Abnormality of glycolipid metabolism (HP:0010969) | 1.99172206 |
| 118 | Polyneuropathy (HP:0001271) | 1.97275569 |
| 119 | Abnormality of the renal collecting system (HP:0004742) | 1.96636000 |
| 120 | Gastrointestinal infarctions (HP:0005244) | 1.96505225 |
| 121 | Skin rash (HP:0000988) | 1.96072822 |
| 122 | Osteomyelitis (HP:0002754) | 1.95214459 |
| 123 | Recurrent viral infections (HP:0004429) | 1.95191030 |
| 124 | Arterial thrombosis (HP:0004420) | 1.94532039 |
| 125 | Abnormality of chromosome stability (HP:0003220) | 1.94047430 |
| 126 | Cutaneous photosensitivity (HP:0000992) | 1.93992485 |
| 127 | Orchitis (HP:0100796) | 1.92458458 |
| 128 | Abnormality of reticulocytes (HP:0004312) | 1.90788365 |
| 129 | Impaired platelet aggregation (HP:0003540) | 1.89519493 |
| 130 | Abnormal platelet function (HP:0011869) | 1.89519493 |
| 131 | Episodic fever (HP:0001954) | 1.88112667 |
| 132 | Generalized aminoaciduria (HP:0002909) | 1.87636475 |
| 133 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.86987988 |
| 134 | Hepatic necrosis (HP:0002605) | 1.86667126 |
| 135 | 11 pairs of ribs (HP:0000878) | 1.85958000 |
| 136 | Ocular albinism (HP:0001107) | 1.84509743 |
| 137 | Stomatitis (HP:0010280) | 1.83448111 |
| 138 | Acute myeloid leukemia (HP:0004808) | 1.82643075 |
| 139 | Macrocytic anemia (HP:0001972) | 1.80180455 |
| 140 | Premature graying of hair (HP:0002216) | 1.79474969 |
| 141 | Urticaria (HP:0001025) | 1.76120443 |
| 142 | Spinal canal stenosis (HP:0003416) | 1.73331307 |
| 143 | Abnormality of the lumbar spine (HP:0100712) | 1.72154743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK3 | 4.71257196 |
| 2 | STK16 | 4.20515590 |
| 3 | IRAK4 | 3.76766797 |
| 4 | MAP3K12 | 2.83614699 |
| 5 | WEE1 | 2.81277272 |
| 6 | BUB1 | 2.67468844 |
| 7 | TESK1 | 2.56651065 |
| 8 | TEC | 2.47241929 |
| 9 | CDC7 | 2.38684766 |
| 10 | TESK2 | 2.36036537 |
| 11 | TAOK3 | 2.23893700 |
| 12 | PRPF4B | 2.15560402 |
| 13 | FES | 2.12919176 |
| 14 | BLK | 2.10168230 |
| 15 | BTK | 1.98230140 |
| 16 | VRK1 | 1.98054987 |
| 17 | MAP2K3 | 1.82571570 |
| 18 | PIM2 | 1.81325440 |
| 19 | BMPR2 | 1.76514504 |
| 20 | BRSK2 | 1.59112683 |
| 21 | TNK2 | 1.58650078 |
| 22 | ERN1 | 1.53556982 |
| 23 | LIMK1 | 1.52056739 |
| 24 | EIF2AK1 | 1.44993788 |
| 25 | SCYL2 | 1.42431729 |
| 26 | EEF2K | 1.38617258 |
| 27 | CDK6 | 1.38125667 |
| 28 | SRPK1 | 1.37618904 |
| 29 | MAP4K1 | 1.35518187 |
| 30 | EIF2AK2 | 1.34773937 |
| 31 | CAMKK2 | 1.30143793 |
| 32 | NEK2 | 1.23738468 |
| 33 | PKN2 | 1.19721589 |
| 34 | CLK1 | 1.19574726 |
| 35 | PAK4 | 1.19174449 |
| 36 | TBK1 | 1.18862300 |
| 37 | ATR | 1.17535091 |
| 38 | RPS6KA4 | 1.17252576 |
| 39 | IRAK3 | 1.16515246 |
| 40 | DAPK1 | 1.16035556 |
| 41 | MAP3K6 | 1.15597506 |
| 42 | MKNK1 | 1.13537916 |
| 43 | SYK | 1.12675845 |
| 44 | TNIK | 1.11447335 |
| 45 | KIT | 1.08654080 |
| 46 | RIPK4 | 1.08350774 |
| 47 | GRK6 | 1.07990291 |
| 48 | TSSK6 | 1.05364812 |
| 49 | CDK7 | 1.04688994 |
| 50 | FLT3 | 1.02597185 |
| 51 | MYLK | 1.00823806 |
| 52 | CCNB1 | 1.00239124 |
| 53 | CDK12 | 0.95704174 |
| 54 | MKNK2 | 0.94661985 |
| 55 | CAMK1D | 0.91353821 |
| 56 | BRSK1 | 0.89571425 |
| 57 | HIPK2 | 0.89462185 |
| 58 | MAPK4 | 0.89250375 |
| 59 | ABL2 | 0.89088102 |
| 60 | MAP3K8 | 0.87647044 |
| 61 | ZAP70 | 0.86942867 |
| 62 | JAK2 | 0.85313793 |
| 63 | CDK8 | 0.83712017 |
| 64 | RPS6KB2 | 0.82971641 |
| 65 | MAP2K4 | 0.82304801 |
| 66 | RPS6KC1 | 0.81161459 |
| 67 | RPS6KL1 | 0.81161459 |
| 68 | TRPM7 | 0.80978919 |
| 69 | PLK4 | 0.80434968 |
| 70 | ITK | 0.79738716 |
| 71 | PLK1 | 0.76708290 |
| 72 | RPS6KA6 | 0.76500254 |
| 73 | CDK4 | 0.75715655 |
| 74 | IKBKE | 0.75374584 |
| 75 | PIM1 | 0.75309008 |
| 76 | AURKB | 0.75244076 |
| 77 | NEK1 | 0.74063761 |
| 78 | ILK | 0.71861561 |
| 79 | LCK | 0.71606117 |
| 80 | MOS | 0.70623978 |
| 81 | ACVR1B | 0.70002603 |
| 82 | PDK1 | 0.68009071 |
| 83 | LYN | 0.67863264 |
| 84 | TAOK1 | 0.67805150 |
| 85 | LRRK2 | 0.67636249 |
| 86 | IKBKB | 0.67315373 |
| 87 | JAK3 | 0.67038281 |
| 88 | BCKDK | 0.65847658 |
| 89 | VRK2 | 0.65722100 |
| 90 | CAMK1G | 0.64684395 |
| 91 | MAP3K14 | 0.64644098 |
| 92 | TTK | 0.63949413 |
| 93 | RPS6KA2 | 0.63899488 |
| 94 | KDR | 0.63117812 |
| 95 | MAP2K2 | 0.62831200 |
| 96 | STK4 | 0.62696316 |
| 97 | EPHB1 | 0.62631570 |
| 98 | MARK3 | 0.62490798 |
| 99 | NME2 | 0.61018206 |
| 100 | MAP3K5 | 0.60727026 |
| 101 | YES1 | 0.60200229 |
| 102 | MAP3K11 | 0.59342157 |
| 103 | NUAK1 | 0.58987334 |
| 104 | PDPK1 | 0.58519873 |
| 105 | PIK3CG | 0.58519513 |
| 106 | MAPKAPK5 | 0.58076141 |
| 107 | RPS6KA5 | 0.56201814 |
| 108 | CDK19 | 0.56173170 |
| 109 | RPS6KB1 | 0.55238770 |
| 110 | PASK | 0.55207987 |
| 111 | TYK2 | 0.53926320 |
| 112 | CSK | 0.53841632 |
| 113 | TRIB3 | 0.52091962 |
| 114 | TXK | 0.50043585 |
| 115 | GRK7 | 0.50033890 |
| 116 | MAP2K6 | 0.49554904 |
| 117 | HCK | 0.49396566 |
| 118 | RAF1 | 0.49088374 |
| 119 | ABL1 | 0.48005197 |
| 120 | MAPK12 | 0.47361021 |
| 121 | BRD4 | 0.44690283 |
| 122 | PLK3 | 0.44483417 |
| 123 | MAP3K1 | 0.44328454 |
| 124 | PAK1 | 0.44240787 |
| 125 | MAP4K2 | 0.44016246 |
| 126 | TAOK2 | 0.43659872 |
| 127 | STK10 | 0.43521530 |
| 128 | GSK3A | 0.43230325 |
| 129 | MATK | 0.42767080 |
| 130 | CHEK2 | 0.41517844 |
| 131 | PRKCD | 0.39292441 |
| 132 | CHEK1 | 0.39065119 |
| 133 | MAPKAPK3 | 0.38593125 |
| 134 | CSNK2A2 | 0.38398048 |
| 135 | MAPK15 | 0.38016604 |
| 136 | PRKCQ | 0.37583980 |
| 137 | TGFBR1 | 0.37542210 |
| 138 | MAP3K7 | 0.37257251 |
| 139 | CSF1R | 0.37075957 |
| 140 | MAPKAPK2 | 0.36986209 |
| 141 | AURKA | 0.36745913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.18058913 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.67486097 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.30598322 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.18056794 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.95658699 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.94654017 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.77416852 |
| 8 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.69332639 |
| 9 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.46296095 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.26735383 |
| 11 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.20385569 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.10169900 |
| 13 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.96467447 |
| 14 | Spliceosome_Homo sapiens_hsa03040 | 1.90205028 |
| 15 | Proteasome_Homo sapiens_hsa03050 | 1.89625566 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.88816535 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.87959686 |
| 18 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.80007943 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.75608043 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.73357069 |
| 21 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.73233265 |
| 22 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.72035781 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.71341902 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.64370605 |
| 25 | Cell cycle_Homo sapiens_hsa04110 | 1.62992885 |
| 26 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.58352020 |
| 27 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.45940835 |
| 28 | Galactose metabolism_Homo sapiens_hsa00052 | 1.44374741 |
| 29 | RNA transport_Homo sapiens_hsa03013 | 1.43948709 |
| 30 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.40570699 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40489178 |
| 32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.38859615 |
| 33 | RNA polymerase_Homo sapiens_hsa03020 | 1.32999917 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.25504016 |
| 35 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.23090058 |
| 36 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.18760444 |
| 37 | RNA degradation_Homo sapiens_hsa03018 | 1.14882172 |
| 38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.14642402 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.11843037 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.11341107 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.09916614 |
| 42 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.09476781 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.06874642 |
| 44 | Amoebiasis_Homo sapiens_hsa05146 | 1.05813616 |
| 45 | Asthma_Homo sapiens_hsa05310 | 1.05291385 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.03895199 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03005982 |
| 48 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.02260982 |
| 49 | Purine metabolism_Homo sapiens_hsa00230 | 1.00614063 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.97039917 |
| 51 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.94990500 |
| 52 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.92156647 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90903786 |
| 54 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.88477387 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87756456 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.87728262 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 0.86236110 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85132896 |
| 59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82519124 |
| 60 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79902779 |
| 61 | Lysosome_Homo sapiens_hsa04142 | 0.79429394 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76281896 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75299005 |
| 64 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.73575081 |
| 65 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.73307996 |
| 66 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.71569004 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71133958 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70703684 |
| 69 | Basal transcription factors_Homo sapiens_hsa03022 | 0.68684156 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.68316002 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67297155 |
| 72 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.65680761 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61362802 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.61337791 |
| 75 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.61107411 |
| 76 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.60614731 |
| 77 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.59644462 |
| 78 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.59529915 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58997958 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57480778 |
| 81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56098705 |
| 82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55704932 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.55271585 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55129076 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54000905 |
| 86 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.53452143 |
| 87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52810750 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52564637 |
| 89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52344095 |
| 90 | Measles_Homo sapiens_hsa05162 | 0.52214686 |
| 91 | Apoptosis_Homo sapiens_hsa04210 | 0.51670788 |
| 92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50208951 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50094122 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50048959 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49997840 |
| 96 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.48316544 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48253635 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48097092 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.47397065 |
| 100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46371048 |
| 101 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45466567 |
| 102 | Histidine metabolism_Homo sapiens_hsa00340 | 0.44385386 |
| 103 | Shigellosis_Homo sapiens_hsa05131 | 0.44311514 |
| 104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.42330092 |
| 105 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.41182409 |
| 106 | Salmonella infection_Homo sapiens_hsa05132 | 0.40665110 |
| 107 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.40262577 |
| 108 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.39193278 |
| 109 | Influenza A_Homo sapiens_hsa05164 | 0.38341310 |
| 110 | Salivary secretion_Homo sapiens_hsa04970 | 0.37475762 |
| 111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36629556 |
| 112 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.36173524 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36147101 |
| 114 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.35684008 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.34870552 |
| 116 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.34025068 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33489223 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33056123 |
| 119 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32898036 |
| 120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32684904 |
| 121 | Platelet activation_Homo sapiens_hsa04611 | 0.32431505 |
| 122 | Hepatitis B_Homo sapiens_hsa05161 | 0.31830532 |
| 123 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.30328808 |
| 124 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29860417 |
| 125 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.29261610 |
| 126 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.29227756 |
| 127 | ABC transporters_Homo sapiens_hsa02010 | 0.28733396 |
| 128 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.28708124 |
| 129 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.28296504 |
| 130 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.28094212 |
| 131 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.27899889 |

